90 results
8-K
EX-99.1
CGTX
Cognition Therapeutics Inc
26 Mar 24
Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
7:12am
, compared to $13.2 million for 2022. The increase was primarily related to higher employee compensation and benefits driven by increased headcount
8-K
EX-1.1
33adf
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
424B5
0r5n bjhcl4aybq2
13 Mar 24
Prospectus supplement for primary offering
4:04pm
424B5
wrkd6rhu jg5j
11 Mar 24
Prospectus supplement for primary offering
4:06pm
424B4
129y ppale4
8 Jan 24
Prospectus supplement with pricing info
4:11pm
8-K
EX-10.1
8lx04if8gbp
1 May 23
Departure of Directors or Certain Officers
7:30am
8-K
EX-10.1
2ziow2 6a
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
S-3
y86gxymr
23 Dec 22
Shelf registration
4:16pm
S-3
EX-1.2
bg92vu04qjvm6v3w9
23 Dec 22
Shelf registration
4:16pm
S-3
EX-4.4
u59o2fr 0bstyxqronbb
23 Dec 22
Shelf registration
4:16pm